Detalhe da pesquisa
1.
Thyroid Cancer: A Review.
JAMA
; 331(5): 425-435, 2024 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319329
Mostrar mais
Texto completo
2.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
N Engl J Med
; 383(9): 825-835, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846061
3.
Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
Support Care Cancer
; 29(5): 2305-2317, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190182
4.
Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features.
J Cutan Pathol
; 46(11): 872-877, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31254410
5.
6.
Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?
Ann Surg Oncol
; 25(11): 3380-3388, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30022274
7.
Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
Cancer
; 123(9): 1653-1661, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28026871
8.
Thyroid cancer.
Lancet
; 388(10061): 2783-2795, 2016 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27240885
9.
Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
Lancet Oncol
; 17(9): 1272-82, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27460442
10.
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.
Cancer
; 121(16): 2749-56, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25913680
11.
Sorafenib in metastatic thyroid cancer: a systematic review.
Oncologist
; 19(3): 251-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24563075
12.
Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer.
Oncologist
; 19(5): 477-82, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24733667
13.
Genomic alterations in thyroid cancer: biological and clinical insights.
Nat Rev Endocrinol
; 20(2): 93-110, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049644
14.
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.
Thyroid
; 34(3): 336-346, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226606
15.
Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer.
Head Neck
; 46(2): 328-335, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009416
16.
Current update on medullary thyroid carcinoma.
AJR Am J Roentgenol
; 201(6): W867-76, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24261394
17.
Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance.
Front Endocrinol (Lausanne)
; 14: 1176731, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435488
18.
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review.
JAMA Oncol
; 9(8): 1132-1141, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289450
19.
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers.
Cell Rep Med
; 4(12): 101332, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118420
20.
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study.
Thyroid
; 33(4): 484-491, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36762947